chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: PPV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a Licensed Practical Nurse and a Registered Nurse referring to a patient of unknown age and gender. Concurrent conditions and medical history of the patient were not reported. On 18-NOV-2015, the patient was vaccinated with a dose of improperly stored PNEUMOVAX 23 (lot# K023328, expiry date 23-JUN-2016) (route and dose unspecified). Other suspect and concomitant therapies were not reported. No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: RV5
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a Licensed Practical Nurse and a Registered Nurse referring to a patient of unknown age and gender. Concurrent conditions and medical history of the patient was not reported. On 07-DEC-2015, the patient was vaccinated with improperly stored dose of ROTATEQ (lot # L000569, expiry date 13-JUL-2016) (dose unspecified) orally. Other suspect and concomitant therapies were not reported. No adverse effects were reported. This is one of several reports received from same source. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a Licensed Practical Nurse and a Registered Nurse referring to multiple unspecified patients of unknown age and gender. Concurrent conditions and medical history of the patients were not reported. On unspecified dates the patients were vaccinated with improperly stored dose of MMRII (lot # K009192, expiry date 27-JUN-2016, lot# K003822, expiry date 14-MAR-2016) (route and dose unspecified) orally. Other suspect and concomitant therapies were not reported. No adverse effects were reported. This is one of several reports received from same source. Additional information has been requested.
Sex: U
Vaccine: HEPA
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. Information regarding relevant medical history and concurrent condition were not reported. On 12-NOV-2015 the patient was vaccinated with VAQTA (lot # L002717, expiration date 02-JUN-2017, dose and route not reported), which was exposed to temperatures outside of the recommended temperature (incorrect product storage). No adverse experience had been reported. This is one of several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. Information regarding relevant medical history and concurrent condition were not reported. On 16-NOV-2015 the patient was vaccinated with MMRII (lot # L012479, expiration date 10-APR-2017, dose and route not reported), which was exposed to temperatures outside of the recommended temperature. No adverse experience had been reported. This is one of several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: HEPA
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. Information regarding relevant medical history and concurrent condition were not reported. On 06-NOV-2015 the patient was vaccinated with VAQTA (lot # L002717, expiration date 02-JUN-2017, dose and route not reported), which was exposed to temperatures outside of the recommended temperature (incorrect product storage). No adverse experience had been reported. This is one of several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: HEPA
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. Information regarding relevant medical history and concurrent condition were not reported. On 02-NOV-2015 the patient was vaccinated with VAQTA (lot # L002717, expiration date 02-JUN-2017, dose and route not reported), which was exposed to temperatures outside of the recommended temperature (incorrect product storage). No adverse experience had been reported. This is one of several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. Information regarding relevant medical history and concurrent condition were not reported. On 18-NOV-2015 the patient was vaccinated with M-M-R II (lot # L012479, expiration date 10-APR-2017, dose and route not reported), which was exposed to temperatures outside of the recommended temperature (incorrect product storage). No adverse experienced had been reported. This is one of several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. Information regarding relevant medical history and concurrent condition were not reported. On 11-NOV-2015 the patient was vaccinated with MMRII (lot # L012479, expiration date 10-APR-2017, dose and route not reported), which was exposed to temperatures outside of the recommended temperature. No adverse experience had been reported. This is one of several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. Information regarding relevant medical history and concurrent condition were not reported. On 12-NOV-2015 the patient was vaccinated with MMRII (lot # L012479, expiration date 10-APR-2017, dose and route not reported), which was exposed to temperatures outside of the recommended temperature. No adverse experience had been reported. This is one of several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. Information regarding relevant medical history and concurrent condition were not reported. On 10-NOV-2015 the patient was vaccinated with MMRII (lot # L012479, expiration date 10-APR-2017, dose and route not reported), which was exposed to temperatures outside of the recommended temperature. No adverse experience had been reported. This is one of several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. Information regarding relevant medical history and concurrent condition were not reported. On 09-NOV-2015 the patient was vaccinated with MMRII (lot # L012479, expiration date 10-APR-2017, dose and route not reported), which was exposed to temperatures outside of the recommended temperature. No adverse experience had been reported. This is one of several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. Information regarding relevant medical history and concurrent condition were not reported. On 06-NOV-2015 the patient was vaccinated with M-M-R II (lot # L012479, expiration date 10-APR-2017, dose and route not reported), which was exposed to temperatures outside of the recommended temperature (incorrect product storage). No adverse experience had been reported. This is one of several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. Information regarding relevant medical history and concurrent condition were not reported. On 02-DEC-2015 the patient was vaccinated with MMRII (lot # L001336, expiration date 13-JAN-2017, dose and route not reported), which was exposed to temperatures outside of the recommended temperature. No adverse experience had been reported. This is one of several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. Information regarding relevant medical history and concurrent condition were not reported. On 04-NOV-2015 the patient was vaccinated with MMRII (lot # L012479, expiration date 10-APR-2017, dose and route not reported), which was exposed to temperatures outside of the recommended temperature. No adverse experience had been reported. This is one of several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: HEPA
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. Information regarding relevant medical history and concurrent condition were not reported. On 09-NOV-2015 the patient was vaccinated with VAQTA (lot # L002717, expiration date 02-JUN-2017, dose and route not reported), which was exposed to temperatures outside of the recommended temperature (incorrect product storage). No adverse experience had been reported. This is one of several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: RV5
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. Information regarding relevant medical history and concurrent condition were not reported. On 09-NOV-2015 the patient was vaccinated with ROTATEQ (lot # L008057, expiration date 01-DEC-2016, oral, dose not reported), which was exposed to temperatures outside of the recommended temperature. No adverse experience had been reported. This is one of several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: HEPA
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. Information regarding relevant medical history and concurrent condition were not reported. On 02-DEC-2015 the patient was vaccinated with VAQTA (lot # L002717, expiration date 02-JUN-2017, dose and route not reported), which was exposed to temperatures outside of the recommended temperature (incorrect product storage). No adverse experience had been reported. This is one of several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: RV5
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. Information regarding relevant medical history and concurrent condition were not reported. On 13-NOV-2015 the patient was vaccinated with ROTATEQ (lot # L008057, expiration date 01-DEC-2016, oral, dose not reported), which was exposed to temperatures outside of the recommended temperature. No adverse experience had been reported. This is one of several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: HEPA
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. Information regarding relevant medical history and concurrent condition were not reported. On 03-NOV-2015 the patient was vaccinated with VAQTA (lot # L002717, expiration date 02-JUN-2017, dose and route not reported), which was exposed to temperatures outside of the recommended temperature (incorrect product storage). No adverse experience had been reported. This is one of several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: HEPA
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. Information regarding relevant medical history and concurrent condition were not reported. On 04-NOV-2015 the patient was vaccinated with VAQTA (lot # L002717, expiration date 02-JUN-2017, dose and route not reported), which was exposed to temperatures outside of the recommended temperature (incorrect product storage). No adverse experience had been reported. This is one of several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: RV5
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. Information regarding relevant medical history and concurrent condition were not reported. On 24-NOV-2015 the patient was vaccinated with ROTATEQ (lot # L008057, expiration date 01-DEC-2016, oral, dose not reported), which was exposed to temperatures outside of the recommended temperature. No adverse experience had been reported. This is one of several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: RV5
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. Information regarding relevant medical history and concurrent condition were not reported. On 30-NOV-2015 the patient was vaccinated with ROTATEQ (lot # L008057, expiration date 01-DEC-2016, oral, dose not reported), which was exposed to temperatures outside of the recommended temperature. No adverse experience had been reported. This is one of several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: RV5
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. Information regarding relevant medical history and concurrent condition were not reported. On 16-NOV-2015 the patient was vaccinated with ROTATEQ (lot # L008057, expiration date 01-DEC-2016, oral, dose not reported), which was exposed to temperatures outside of the recommended temperature. No adverse experience had been reported. This is one of several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: RV5
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. Information regarding relevant medical history and concurrent condition were not reported. On 18-NOV-2015 the patient was vaccinated with ROTATEQ (lot # L008057, expiration date 01-DEC-2016, oral, dose not reported), which was exposed to temperatures outside of the recommended temperature. No adverse experience had been reported. This is one of several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: RV5
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. Information regarding relevant medical history and concurrent condition were not reported. On 04-NOV-2015 the patient was vaccinated with oral, ROTATEQ (lot # L008057, expiration date 01-DEC-2016, dose not reported), which was exposed to temperatures outside of the recommended temperature (incorrect product storage). No adverse experience had been reported. This is one of several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: RV5
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. Information regarding relevant medical history and concurrent condition were not reported. On 02-NOV-2015 the patient was vaccinated with ROTATEQ (lot # L008057, expiration date 01-DEC-2016, oral, dose not reported), which was exposed to temperatures outside of the recommended temperature. No adverse experience had been reported. This is one of several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a physician's assistant refers to a patient of unknown age and gender. On 05-NOV-2015, the patient was vaccinated with an improperly stored dose of MMRII (lot # K024036 exp date 26-NOV-2016) (dose and route not reported). The temperature excursion was 53.8 F for 10.75 hours from 17-AUG-2015 to 06-NOV-2015. No adverse event was reported. This is one of several reports received from the same source. Additional information is not expected as all follow up information to complete the case was received.
Sex: U
Vaccine: MMRV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a Licensed Practical Nurse referring to an unspecified number of unspecified patients of unknown age and gender. Concurrent conditions and medical history of the patients were not reported. On unknown dates the patients were vaccinated with doses of improperly stored PROQUAD (Merck) (lot # L030585, expiry date 10-FEB-2017) (dose and route unspecified), Other suspect and concomitant therapies were not reported, No adverse effects reported, Additional information has been requested,
Age: 11.0
Sex: F
Vaccine: HPV4, MEN
Symptoms: White blood cell count decreased
Clinical narrative: Information has been received from a pharmacist referring to her 11 year old daughter who had no drug allergies/reactions. The patient had a complete blood count drawn on 24-DEC-2014, which showed that her white blood cell count was normal. On 13-JUL-2015 the patient had her first dose of unidentified Merck HPV vaccine administered (name, lot number and dose were not provided) intramuscularly. Concomitant therapy included an unspecified meningococcal vaccine (manufacturer unspecified) which was also vaccinated on the same date. The patient had a routine follow-up complete blood count drawn on 04-SEP-2015 which showed that her white blood cell count was low (pharmacist stated the report did not include an actual value). No treatment was given for the adverse event. The patient had not yet had another follow-up complete blood count drawn to determine whether this issue had resolved. The pharmacist stated due to this issue, she was uncertain at this point whether patient would complete the Merck HPV vaccine series. Additional information has been requested.
Sex: U
Vaccine: RV5
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. Information regarding relevant medical history and concurrent condition were not reported. On 25-NOV-2015 the patient was vaccinated with oral, ROTATEQ (lot # L008057, expiration date 01-DEC-2016, oral, dose not reported) which was exposed to temperatures outside of the recommended temperature (incorrect product storage). No adverse experience had been reported. This is one of several reports received from the same source. Additional information has been requested.
Age: 88.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Dyspnoea
Clinical narrative: Immediately after receiving injection - great difficulty breathing requiring activating EMS. Nausea, diarrhea, general malaise several hrs later.
Age: 88.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Diarrhoea, Dyspnoea, Immediate post-injection reaction, Malaise, Nausea
Clinical narrative: Immediately after receiving injection - great difficulty breathing requiring activating EMS. Nausea, diarrhea, general malaise several hrs later.
Age: 58.0
Sex: F
Vaccine: FLUX, MMRV
Symptoms: Condition aggravated, Hypersensitivity, Rhinorrhoea, Sneezing
Clinical narrative: I have been allergy free for 10 years... I received my first flu vaccine 3 years ago and immediately I had to go back on Chlorpheniramine Maleate due to constant sneezing & runny nose....every year after that I received the flu vaccine and I had to increase the dose of my medication because the symptoms got worse after each flu vaccine...I am an RN and I believe the flu vaccine exacerbates allergies and you need to consider that as a side effect of the flu vaccine, as I continue to get worse every year I have taken it....
Age: 2.0
Sex: F
Vaccine: MMR
Symptoms: Allergy test negative, Food aversion, Occult blood negative, Rash erythematous
Clinical narrative: Onset date is first observed date. Subject develops rash (red dots) around mouth while eating certain previously safe foods. With continued consumption of the problem foods, rash spreads across the face. Subject also displays unusual aversion to some of the problem foods. Rash begins within a few minutes of ingestion and gradually fades over hours. With repeated ingestion red marks remain on face for days. Two professional feeding therapists were first to notice the rash on the given date, and also had never observed subject to develop a rash prior to the vaccination (despite close contact over many months). Rash continues to appear more than a half year after first onset. On advice of GI doctor, most symptomatic foods are now avoided. Most reactive foods include common staples such as chicken, potatoes, apples, and various other fruits and vegetables, causing significant negative impact on subject's food intake variety.
Age: 60.0
Sex: F
Vaccine: UNK
Symptoms: Asthenia, Condition aggravated, Decreased appetite, Fatigue, Headache
Clinical narrative: 2 swollen lymph nodes on back of head, swollen right butt cheek, headaches, no appetite, night sweats, sleepy during day, itching all over, very tired and weak (more than usual due to leukemia).
Age: 60.0
Sex: F
Vaccine: UNK
Symptoms: Leukaemia, Local swelling, Lymphadenopathy, Night sweats, Pruritus generalised
Clinical narrative: 2 swollen lymph nodes on back of head, swollen right butt cheek, headaches, no appetite, night sweats, sleepy during day, itching all over, very tired and weak (more than usual due to leukemia).
Age: 60.0
Sex: F
Vaccine: UNK
Symptoms: Somnolence
Clinical narrative: 2 swollen lymph nodes on back of head, swollen right butt cheek, headaches, no appetite, night sweats, sleepy during day, itching all over, very tired and weak (more than usual due to leukemia).
Age: 61.0
Sex: M
Vaccine: FLUC3
Symptoms: Electromyogram, Injection site pain, Muscular weakness, Neck pain
Clinical narrative: Pain in (L) neck and (L) upper shoulder area; developed weakness of (L) arm resolving symptoms developed within a few wks of flu administration.
Age: 16.0
Sex: F
Vaccine: HPV4
Symptoms: Injection site erythema, Injection site pain, Injection site warmth, Skin infection
Clinical narrative: 6 days after vaccine student developed pain at injection site - no redness, (+) warmth. Day 7 follow up - pain, small area of redness and (+) warmth to area continues.
Age: 34.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Cellulitis, Fatigue, Injection site erythema, Injection site pain, Malaise
Clinical narrative: She described a soreness in her arm as well as malaise, soon developed redness, more severe pain in her arm approx. 4cm below the injection site. This worsened over the next few days. She visited an ER 4 days after the injection due to severe left arm pain and fever, severe malaise/fatigue. She was diagnosed with cellulitis and treated with IV antibiotics. 1-2 days afterwards she felt much better and the pain started to subside as well as her malaise/fever/fatigue. At this time she has minor left arm soreness and only a slight redness to the skin.
Age: 34.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: She described a soreness in her arm as well as malaise, soon developed redness, more severe pain in her arm approx. 4cm below the injection site. This worsened over the next few days. She visited an ER 4 days after the injection due to severe left arm pain and fever, severe malaise/fatigue. She was diagnosed with cellulitis and treated with IV antibiotics. 1-2 days afterwards she felt much better and the pain started to subside as well as her malaise/fever/fatigue. At this time she has minor left arm soreness and only a slight redness to the skin.
Age: 32.0
Sex: F
Vaccine: FLU3, PNC13
Symptoms: Drug administered to patient of inappropriate age
Clinical narrative: None.
Age: 16.0
Sex: M
Vaccine: HPV9, MENB
Symptoms: Injection site pain, Injection site swelling
Clinical narrative: Extreme pain (8 out of 10) with baseball size swelling at the injection site.  No redness or heat.
Age: 4.0
Sex: M
Vaccine: MMRV
Symptoms: Varicella post vaccine
Clinical narrative: Pt developed varicella after having both the VARIVAX vaccine and the MMRV.
Age: 47.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site bruising, Injection site reaction, Skin disorder
Clinical narrative: Got flu vaccine 11/13/15. Still has bruise and indentation where shot was given. Having pain in (L) arm and neck and shoulder. These pains got worse after flu vaccine.
Age: 4.0
Sex: F
Vaccine: DTAPIPV, HEPA, PPV
Symptoms: Cellulitis, Condition aggravated, Dehydration, Differential white blood cell count normal, Full blood count normal
Clinical narrative: Inflammation (L) thigh 12/10/15 - 12/11/15 at injection site of 12/9/15 PCV 23 and KINRIX vacc. instruc. to apply cool compress and ice 12/12 - cellulitis dev and admit to hospital Rx ROCEPHIN at hospital. Pt h/o hyper IgD syndrome - has flare ups after immun with fever, vom occassionally leading to dehyd., and pain and rash - this flare up f/u ID -> delayed no rash, no pain.
Age: 4.0
Sex: F
Vaccine: DTAPIPV, HEPA, PPV
Symptoms: Hyper IgD syndrome, Injection site inflammation, Nuclear magnetic resonance imaging abnormal, Pain, Pyrexia
Clinical narrative: Inflammation (L) thigh 12/10/15 - 12/11/15 at injection site of 12/9/15 PCV 23 and KINRIX vacc. instruc. to apply cool compress and ice 12/12 - cellulitis dev and admit to hospital Rx ROCEPHIN at hospital. Pt h/o hyper IgD syndrome - has flare ups after immun with fever, vom occassionally leading to dehyd., and pain and rash - this flare up f/u ID -> delayed no rash, no pain.
Age: 4.0
Sex: F
Vaccine: DTAPIPV, HEPA, PPV
Symptoms: Rash, Vomiting
Clinical narrative: Inflammation (L) thigh 12/10/15 - 12/11/15 at injection site of 12/9/15 PCV 23 and KINRIX vacc. instruc. to apply cool compress and ice 12/12 - cellulitis dev and admit to hospital Rx ROCEPHIN at hospital. Pt h/o hyper IgD syndrome - has flare ups after immun with fever, vom occassionally leading to dehyd., and pain and rash - this flare up f/u ID -> delayed no rash, no pain.
Age: 66.0
Sex: U
Vaccine: FLU3
Symptoms: Eyelid margin crusting, Limb discomfort, Malaise, Nodule, Pain
Clinical narrative: Tasted median, throat swelling, knot, itching, sick/aches, eyes matted shut by 11/30/15, legs heavy.
Age: 66.0
Sex: U
Vaccine: FLU3
Symptoms: Pharyngeal oedema, Pruritus
Clinical narrative: Tasted median, throat swelling, knot, itching, sick/aches, eyes matted shut by 11/30/15, legs heavy.
Age: 78.0
Sex: F
Vaccine: PNC13
Symptoms: Chest X-ray abnormal, Cough, Fatigue, Headache, Oropharyngeal pain
Clinical narrative: By 8/9 I was feverish, exhausted, had headaches, sore throat and was coughing so hard I ached all over. Finally on 8/18 I went to Dr. He took chest x-ray and told me I had pneumonia, took azithromycin for 5 days.
Age: 78.0
Sex: F
Vaccine: PNC13
Symptoms: Pain, Pneumonia, Pyrexia
Clinical narrative: By 8/9 I was feverish, exhausted, had headaches, sore throat and was coughing so hard I ached all over. Finally on 8/18 I went to Dr. He took chest x-ray and told me I had pneumonia, took azithromycin for 5 days.
Age: 61.0
Sex: F
Vaccine: FLU3
Symptoms: Audiogram, Deafness neurosensory, Deafness unilateral, Nuclear magnetic resonance imaging, Sudden hearing loss
Clinical narrative: On Oct. 8 received Flu vaccine. On Oct 12, lost most hearing left ear. Diagnosed by ENT w/Idiopathic Sensorineural Sudden Hearing loss. Treated w cortisone, oral and intratympanic.
Age: 68.0
Sex: F
Vaccine: PNC13
Symptoms: Condition aggravated, Guillain-Barre syndrome, Limb discomfort, Lumbar puncture abnormal, Muscular weakness
Clinical narrative: Tingling and heaviness in extremities, muscle weakness (+) Guillain-Barre. (Recurrence, prior event 17 yr ago).
Age: 68.0
Sex: F
Vaccine: PNC13
Symptoms: Paraesthesia
Clinical narrative: Tingling and heaviness in extremities, muscle weakness (+) Guillain-Barre. (Recurrence, prior event 17 yr ago).
Age: 53.0
Sex: M
Vaccine: FLU3
Symptoms: Angiogram, Arthralgia, Coagulation test, Deep vein thrombosis, Echocardiogram
Clinical narrative: Pain in back of left knee 8 hours after Flu vaccine injection. Pain and noticeable swelling in left calf by morning. Severe pain upon walking and standing. Saw Dr on 11/17/2015; he sent me to radiology at Medical Center where a blood clot (DVT) was detected in left leg from calf to groin. Admitted into Emergency Room immediately. Treated with LOVENOX and oral warfarin. 4 days in hospital. XARELTO prescribed.
Age: 53.0
Sex: M
Vaccine: FLU3
Symptoms: Pain, Pain in extremity, Peripheral swelling, Ultrasound Doppler abnormal
Clinical narrative: Pain in back of left knee 8 hours after Flu vaccine injection. Pain and noticeable swelling in left calf by morning. Severe pain upon walking and standing. Saw Dr on 11/17/2015; he sent me to radiology at Medical Center where a blood clot (DVT) was detected in left leg from calf to groin. Admitted into Emergency Room immediately. Treated with LOVENOX and oral warfarin. 4 days in hospital. XARELTO prescribed.
Age: 66.0
Sex: F
Vaccine: FLU3
Symptoms: Abasia, Drooling, Dysphagia, Dyspnoea, Heart rate increased
Clinical narrative: I took shot at pharmacy, done fine for about 3 hours, could not swallow, breathing fast, saliva running down my chin, I called Dr. next day and pharmacy made appt. to go in. Laid in bed for 3 days. I get shot every year a pharmacy - same one never hurt me before something in this shot that will kill me.
Age: 66.0
Sex: F
Vaccine: FLU3
Symptoms: Respiratory rate increased
Clinical narrative: I took shot at pharmacy, done fine for about 3 hours, could not swallow, breathing fast, saliva running down my chin, I called Dr. next day and pharmacy made appt. to go in. Laid in bed for 3 days. I get shot every year a pharmacy - same one never hurt me before something in this shot that will kill me.
Age: 38.0
Sex: F
Vaccine: FLU3
Symptoms: Erythema, Injection site erythema, Injection site warmth, Rash macular, Urticaria
Clinical narrative: Arm at site of injection red and hot to the touch. Developed hives on arm, back and neck. Face turned splotchy and red.
Age: 59.0
Sex: M
Vaccine: FLU4, TDAP
Symptoms: Immunoglobulin therapy, Lumbar puncture, Neurological symptom
Clinical narrative: Neurological changes. TX: IVIG.
Age: 29.0
Sex: U
Vaccine: FLU3, PPV
Symptoms: Burning sensation, Erythema, Pain, Pain in extremity, Paraesthesia
Clinical narrative: The patient reported that they can't move their arm without a sharp pain. There is a large red spot between the shoulder and the elbow. It also burns and tingles and hurts when her shirt touches the area. The patient said she would be contacting her primary care physician on Monday.
Age: 29.0
Sex: U
Vaccine: FLU3, PPV
Symptoms: Tenderness
Clinical narrative: The patient reported that they can't move their arm without a sharp pain. There is a large red spot between the shoulder and the elbow. It also burns and tingles and hurts when her shirt touches the area. The patient said she would be contacting her primary care physician on Monday.
Age: 78.0
Sex: F
Vaccine: FLU3
Symptoms: Balance disorder, Blood pressure increased, Fall, Headache, Joint injury
Clinical narrative: Headache, 2 day rash neck - upper chest, unsteady and shaky, fell headlong, hurt shoulders, hands, knees, BP up 175/82 - got physical therapy for injury.
Age: 78.0
Sex: F
Vaccine: FLU3
Symptoms: Limb injury, Rash, Tremor
Clinical narrative: Headache, 2 day rash neck - upper chest, unsteady and shaky, fell headlong, hurt shoulders, hands, knees, BP up 175/82 - got physical therapy for injury.
Age: 71.0
Sex: F
Vaccine: FLU3, PNC13
Symptoms: Arthralgia, Erythema, Eye pain, Herpes zoster, Malaise
Clinical narrative: Shingles (R) scalp: within a week of my vaccinations I had symptoms of shingles; tingly (R) scalp, hive-like line of "rash" base of scalp, pain to elbow (R) arm; this progressed to pain and redness of (R) scalp, another breakout (R) anterior neck; soreness (R) eye. No known fever but malaise and sx of general illness. MD - 11/25/15 misdiagnosed. M.D. 11/29/15 started Famciclovir and Gabapentin. Shingles ongoing. Had shingles vacc. in 2007.
Age: 71.0
Sex: F
Vaccine: FLU3, PNC13
Symptoms: Pain of skin, Paraesthesia, Urticaria
Clinical narrative: Shingles (R) scalp: within a week of my vaccinations I had symptoms of shingles; tingly (R) scalp, hive-like line of "rash" base of scalp, pain to elbow (R) arm; this progressed to pain and redness of (R) scalp, another breakout (R) anterior neck; soreness (R) eye. No known fever but malaise and sx of general illness. MD - 11/25/15 misdiagnosed. M.D. 11/29/15 started Famciclovir and Gabapentin. Shingles ongoing. Had shingles vacc. in 2007.
Age: 65.0
Sex: F
Vaccine: FLU3
Symptoms: Pyrexia, Tremor
Clinical narrative: Tremors and low grade fever which has subsided.
Age: 75.0
Sex: M
Vaccine: FLU3
Symptoms: Feeling abnormal, Toothache
Clinical narrative: Dull throbbing on-off like a real small toothache, at times feels like something isn't right still. 2 months < later into Dec. 2015.
Age: 63.0
Sex: F
Vaccine: FLU3, VARZOS
Symptoms: Feeling abnormal, Headache, Injection site erythema, Skin warm
Clinical narrative: Client called, reported 2 days after vaccine given, injection site reddened (2 in) with pink raised area (4-5 in) down arm towards elbow. No fever, no pain, has headaches (normal for her), arm "felt weird" warm to touch. Explained if it got worse or not improving, seek medical attention. Arm back to normal in 1-2 days.
Age: 35.0
Sex: F
Vaccine: FLU4
Symptoms: Injection site pain
Clinical narrative: Flu shot given high on upper right arm, close to shoulder. Rt shoulder pain.
Age: 75.0
Sex: F
Vaccine: FLU3
Symptoms: Pain, Sleep disorder
Clinical narrative: The normal pain from a flu shot never went away, just got worse. I have had flu shots for 47 years and this has never happened.  It hurts to use my arm, sleep on that side, reach backwards, etc.
Age: 17.0
Sex: F
Vaccine: FLU4
Symptoms: Erythema, Local reaction, Pain, Pain in extremity, Swelling
Clinical narrative: Patient said she had bad arm pain the evening following vaccination and took ibuprofen and it helped some.  Today she feels very sore and has a localized reaction measure 4 to 5 inches in the shape of a circle with redness/swelling.  She has tolerated flu vaccines previously without issues.
Age: 66.0
Sex: F
Vaccine: VARZOS
Symptoms: Neuralgia, Rash
Clinical narrative: PATIENT WAS OUT OF TOWN AND HAD RASH ON ABDOMEN AND BACK, PATIENT CAME BACK AFTER ONE YEAR AND SHE COMPLAINS OF NERVE PAIN, PATIENT WENT TO REGULAR PHYSICAIN AND THEY TOLD HER IT'S NOT SHINGLES BUT SHE STILL HAS RASH AND PAIN.
Age: 43.0
Sex: F
Vaccine: FLU3
Symptoms: Angiogram cerebral, Back pain, Blood test, Blood thyroid stimulating hormone, Chest X-ray normal
Clinical narrative: At 3 AM on 12/19/15 I woke up with numb/tingling and cold feet, a temperature of 102.9, generalized body aches and chills, chest and back pain, and nausea. I was brought into the emergency department by my husband. Lab work and chest xray came back normal and I was informed the cause for symptoms was unknown but they may be related to receiving the flu vaccine and instructed to come back if my symptoms, especially if my neurological symptoms, increased or if I developed new symptoms and I was discharged home. I continued to run a low grade fever, and continued with numb/tingling feet, and generalized feeling of not feeling well. I woke up 12/20/19 at 8:00 am feeling numbness and tingling on the left side of my face and noticed I was drooling from the left side of my mouth. My family noted the left side of my face was drooping. Again my family brought me into Emergency department. The doctors there worked me up for stroke which was negative and it was determined I had recurrent Bells Palsy. I was given a prescription for Prednisone and Valacyclovir and discharged home. I later found out in people with a history of certain Bell's palsy the flu vaccine is not recommended and discovered cases of Bells Palsy after receiving the vaccine have been reported. I was never asked in the screening questions prior to receiving the flu vaccine if I had Bell's Palsy.
Age: 43.0
Sex: F
Vaccine: FLU3
Symptoms: Chest pain, Chills, Computerised tomogram head, Condition aggravated, Drooling
Clinical narrative: At 3 AM on 12/19/15 I woke up with numb/tingling and cold feet, a temperature of 102.9, generalized body aches and chills, chest and back pain, and nausea. I was brought into the emergency department by my husband. Lab work and chest xray came back normal and I was informed the cause for symptoms was unknown but they may be related to receiving the flu vaccine and instructed to come back if my symptoms, especially if my neurological symptoms, increased or if I developed new symptoms and I was discharged home. I continued to run a low grade fever, and continued with numb/tingling feet, and generalized feeling of not feeling well. I woke up 12/20/19 at 8:00 am feeling numbness and tingling on the left side of my face and noticed I was drooling from the left side of my mouth. My family noted the left side of my face was drooping. Again my family brought me into Emergency department. The doctors there worked me up for stroke which was negative and it was determined I had recurrent Bells Palsy. I was given a prescription for Prednisone and Valacyclovir and discharged home. I later found out in people with a history of certain Bell's palsy the flu vaccine is not recommended and discovered cases of Bells Palsy after receiving the vaccine have been reported. I was never asked in the screening questions prior to receiving the flu vaccine if I had Bell's Palsy.
Age: 43.0
Sex: F
Vaccine: FLU3
Symptoms: Full blood count, Hypoaesthesia, Laboratory test normal, Malaise, Metabolic function test
Clinical narrative: At 3 AM on 12/19/15 I woke up with numb/tingling and cold feet, a temperature of 102.9, generalized body aches and chills, chest and back pain, and nausea. I was brought into the emergency department by my husband. Lab work and chest xray came back normal and I was informed the cause for symptoms was unknown but they may be related to receiving the flu vaccine and instructed to come back if my symptoms, especially if my neurological symptoms, increased or if I developed new symptoms and I was discharged home. I continued to run a low grade fever, and continued with numb/tingling feet, and generalized feeling of not feeling well. I woke up 12/20/19 at 8:00 am feeling numbness and tingling on the left side of my face and noticed I was drooling from the left side of my mouth. My family noted the left side of my face was drooping. Again my family brought me into Emergency department. The doctors there worked me up for stroke which was negative and it was determined I had recurrent Bells Palsy. I was given a prescription for Prednisone and Valacyclovir and discharged home. I later found out in people with a history of certain Bell's palsy the flu vaccine is not recommended and discovered cases of Bells Palsy after receiving the vaccine have been reported. I was never asked in the screening questions prior to receiving the flu vaccine if I had Bell's Palsy.
Age: 43.0
Sex: F
Vaccine: FLU3
Symptoms: Nausea, Nuclear magnetic resonance imaging brain, Pain, Paraesthesia, Peripheral coldness
Clinical narrative: At 3 AM on 12/19/15 I woke up with numb/tingling and cold feet, a temperature of 102.9, generalized body aches and chills, chest and back pain, and nausea. I was brought into the emergency department by my husband. Lab work and chest xray came back normal and I was informed the cause for symptoms was unknown but they may be related to receiving the flu vaccine and instructed to come back if my symptoms, especially if my neurological symptoms, increased or if I developed new symptoms and I was discharged home. I continued to run a low grade fever, and continued with numb/tingling feet, and generalized feeling of not feeling well. I woke up 12/20/19 at 8:00 am feeling numbness and tingling on the left side of my face and noticed I was drooling from the left side of my mouth. My family noted the left side of my face was drooping. Again my family brought me into Emergency department. The doctors there worked me up for stroke which was negative and it was determined I had recurrent Bells Palsy. I was given a prescription for Prednisone and Valacyclovir and discharged home. I later found out in people with a history of certain Bell's palsy the flu vaccine is not recommended and discovered cases of Bells Palsy after receiving the vaccine have been reported. I was never asked in the screening questions prior to receiving the flu vaccine if I had Bell's Palsy.
Age: 43.0
Sex: F
Vaccine: FLU3
Symptoms: Pyrexia, VIIth nerve paralysis
Clinical narrative: At 3 AM on 12/19/15 I woke up with numb/tingling and cold feet, a temperature of 102.9, generalized body aches and chills, chest and back pain, and nausea. I was brought into the emergency department by my husband. Lab work and chest xray came back normal and I was informed the cause for symptoms was unknown but they may be related to receiving the flu vaccine and instructed to come back if my symptoms, especially if my neurological symptoms, increased or if I developed new symptoms and I was discharged home. I continued to run a low grade fever, and continued with numb/tingling feet, and generalized feeling of not feeling well. I woke up 12/20/19 at 8:00 am feeling numbness and tingling on the left side of my face and noticed I was drooling from the left side of my mouth. My family noted the left side of my face was drooping. Again my family brought me into Emergency department. The doctors there worked me up for stroke which was negative and it was determined I had recurrent Bells Palsy. I was given a prescription for Prednisone and Valacyclovir and discharged home. I later found out in people with a history of certain Bell's palsy the flu vaccine is not recommended and discovered cases of Bells Palsy after receiving the vaccine have been reported. I was never asked in the screening questions prior to receiving the flu vaccine if I had Bell's Palsy.
Age: 76.0
Sex: M
Vaccine: PPV
Symptoms: Erythema, Pain in extremity, Peripheral swelling, Pyrexia
Clinical narrative: Swelling, pain and erythema in the deltoid area, initially localized, but spreading over a period of hours to include the entire deltoid area and adjacent areas, both laterally and posteriorly.  Fever up to 102.0 F started within several hours.  The swelling and erythema extended over the next few days to the mid-forearm.  Treatment consisted of acetaminophen.  By 12/21/2015 all signs and symptoms had resolved.
Age: 74.0
Sex: F
Vaccine: FLU3
Symptoms: Chest pain, Palpitations, Pruritus, Rash
Clinical narrative: Rash over body from groin all the way up including arms, itching; started 48 hours post shot; also for 30 min. has chest burning and heart palpitation. Second tome this happened, first was w/steroid injection of knee. Also occurred after 48 hours; pt took ZYRTEC (pt allergic to BENADRYL).
Age: 56.0
Sex: F
Vaccine: FLU3
Symptoms: Bursitis
Clinical narrative: On 11/19/2015 patient was seen in ER for bursitis from reaction to flu vaccine on 10/29/2015. Patient advises recommendation for therapy twice weekly.
Age: 0.63
Sex: M
Vaccine: DTAPIPVHIB, FLU3, HEP, PNC13
Symptoms: Autopsy, Bacterial test, CSF culture negative, CSF test abnormal, Death
Clinical narrative: Child died while sleeping. No reported evidence of illness prior to death.
Age: 0.63
Sex: M
Vaccine: DTAPIPVHIB, FLU3, HEP, PNC13
Symptoms: Fungal test, Viral test
Clinical narrative: Child died while sleeping. No reported evidence of illness prior to death.
Age: 23.0
Sex: F
Vaccine: FLU4
Symptoms: Asthma, Chest pain, Condition aggravated, Peripheral swelling, Throat tightness
Clinical narrative: Employee reports she "felt chest pain and her throat closed up. Took Benadryl and went to bed. She reports she took Benadryl again the next day and went to work, where she then noticed her arm was swollen and reports she had an asthma attack. She went to the ED for treatment, where she reported it as a "flu reaction".
Age: 72.0
Sex: M
Vaccine: FLU3
Symptoms: Urticaria
Clinical narrative: Few hours after vaccine urticaria x 5 days 11/6/15 - 11/10/15.
Age: 49.0
Sex: F
Vaccine: PNC13
Symptoms: Injection site erythema, Injection site pain, Injection site warmth
Clinical narrative: Pt soon developed 2 wks of mod-severe pain at site of injection after injection. Area red and hot to touch per pt.
Age: 75.0
Sex: F
Vaccine: FLU3, PNC13
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Redness, swelling, warm skin site of administration (left arm). Her doctor prescribe: Doxycycline 100 mg BID (one tab twice a day).
Age: 74.0
Sex: F
Vaccine: FLU3
Symptoms: Vomiting
Clinical narrative: Vomiting starting a few hours after given vaccine, resolving within a few hours.
Age: 65.0
Sex: F
Vaccine: PNC13
Symptoms: Immediate post-injection reaction, Musculoskeletal pain, Sleep disorder, X-ray
Clinical narrative: Immediately upon Prevnar being injected into my upper left arm, I had pain in my left shoulder blade.  I took prednisone, had 10 PT sessions (continue to do exercises), and received a cortisone shot.  Pain continues esp. in bed.
Age: 58.0
Sex: F
Vaccine: FLU3
Symptoms: Injected limb mobility decreased, Injection site pain
Clinical narrative: Employee reports she had "pain/difficulty moving right shoulder after flu vaciantion".
Age: 17.0
Sex: M
Vaccine: FLUN4, HPV9, MNQ
Symptoms: Rash, Rash pruritic
Clinical narrative: Itchy rash started on arms and legs the evening after the vaccines were given and progressively got worse and spread.
Age: 1.23
Sex: M
Vaccine: DTAPIPVHIB, FLU4, HEPA, MMR, PNC13, VARCEL
Symptoms: Abdominal distension, Alanine aminotransferase increased, Ascites, Aspartate aminotransferase increased, Blood albumin decreased
Clinical narrative: 15 months old admitted to Hospital on 12/18/15 with a four-day history of vomiting, diarrhea and a 2 day history of abdominal distention.  On admission had ascites, elevated liver enzymes and elevated LDH.  Child is still in in the hospital and is improving. Pediatric gastroenterologist diagnosis is most likely post infectious enteritis.